{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-292567","form_type":"8-K","ticker":"CLYM","cik":"0001768446","company_name":"Climb Bio, Inc.","filed_at":"2026-07-01T20:15:31+00:00","discovered_at":"2026-07-01T20:17:00.439392+00:00","generated_at":"2026-07-01T20:17:19.796573+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Climb Bio director Andrew Levin resigns; Breanna O'Reilly elected to board","bullets":["Andrew Levin resigned from the board effective June 29, 2026.","Breanna O'Reilly, Ph.D., elected as director effective June 29, 2026.","O'Reilly received option for 70,284 shares at $13.36, vesting over 3 years.","O'Reilly to receive $40,000 annual cash retainer and annual equity grants.","No family relationships or related-party transactions with O'Reilly."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-292567","json":"https://secwatch.observer/filing/0001193125-26-292567.json","markdown":"https://secwatch.observer/filing/0001193125-26-292567.md","text":"https://secwatch.observer/filing/0001193125-26-292567.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768446/000119312526292567/0001193125-26-292567-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768446/000119312526292567/d61061d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T20:17:19.796573+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}